Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Sci Rep ; 6: 20643, 2016 Feb 11.
Artículo en Inglés | MEDLINE | ID: mdl-26865366

RESUMEN

Tendon injury during limb motion is common. Damaged tendons heal poorly and frequently undergo unpredictable ruptures or impaired motion due to insufficient innate healing capacity. By basic fibroblast growth factor (bFGF) or vascular endothelial growth factor (VEGF) gene therapy via adeno-associated viral type-2 (AAV2) vector to produce supernormal amount of bFGF or VEGF intrinsically in the tendon, we effectively corrected the insufficiency of the tendon healing capacity. This therapeutic approach (1) resulted in substantial amelioration of the low growth factor activity with significant increases in bFGF or VEGF from weeks 4 to 6 in the treated tendons (p < 0.05 or p < 0.01), (2) significantly promoted production of type I collagen and other extracellular molecules (p < 0.01) and accelerated cellular proliferation, and (3) significantly increased tendon strength by 68-91% from week 2 after AAV2-bFGF treatment and by 82-210% from week 3 after AAV2-VEGF compared with that of the controls (p < 0.05 or p < 0.01). Moreover, the transgene expression dissipated after healing was complete. These findings show that the gene transfers provide an optimistic solution to the insufficiencies of the intrinsic healing capacity of the tendon and offers an effective therapeutic possibility for patients with tendon disunion.


Asunto(s)
Dependovirus/genética , Factor 2 de Crecimiento de Fibroblastos/genética , Traumatismos de los Tendones/terapia , Factor A de Crecimiento Endotelial Vascular/genética , Cicatrización de Heridas/genética , Animales , Proliferación Celular , Pollos , Colágeno Tipo I/agonistas , Colágeno Tipo I/genética , Colágeno Tipo I/metabolismo , Dependovirus/metabolismo , Factor 2 de Crecimiento de Fibroblastos/agonistas , Factor 2 de Crecimiento de Fibroblastos/metabolismo , Fibronectinas/agonistas , Fibronectinas/genética , Fibronectinas/metabolismo , Regulación de la Expresión Génica , Terapia Genética/métodos , Vectores Genéticos/química , Vectores Genéticos/metabolismo , Laminina/agonistas , Laminina/genética , Laminina/metabolismo , Cultivo Primario de Células , Traumatismos de los Tendones/genética , Traumatismos de los Tendones/metabolismo , Traumatismos de los Tendones/patología , Tendones/metabolismo , Tendones/patología , Tenocitos/citología , Tenocitos/metabolismo , Resistencia a la Tracción , Transgenes , Factor A de Crecimiento Endotelial Vascular/agonistas , Factor A de Crecimiento Endotelial Vascular/metabolismo
2.
Curr Neurovasc Res ; 9(2): 110-9, 2012 May.
Artículo en Inglés | MEDLINE | ID: mdl-22475395

RESUMEN

We recently demonstrated a dramatic up regulation of laminin expression within the blood vessels of brain regions vulnerable to excitotoxin mediated neuronal degeneration. Although this effect was clearly demonstrable at 2 days post kainic acid exposure, its expression at shorter and longer post-dosing intervals has not been reported. Therefore, a primary goal of the present study was to characterize the laminin labeling at intervals ranging from 4 hours to 2 months following i.p. injection of kainic acid. To better characterize the nature and possible underlying mechanism of action of the changes in laminin expression, both Fluoro-Jade C and GFAP immunohistochemistry were employed respectively at all survival intervals. At the shortest intervals examined (4hr, 8hr), Fluoro-Jade C positive cells could be detected in the hippocampus, thalamus, and piriform cortex. In these same regions, both vascular laminin and astrocytic GFAP expression were up regulated. At intermediate survival intervals (2, 5, 14, and 21 days), the respective labeling of degenerating neurons, astrocytes and capillaries were all maximal. Morphologically, Fluoro-Jade C labeled degenerating neurons were labeled in their entirety, GFAP positive astrocytes appeared hypertrophic and blood vessels took on a fragmented appearance. Hypertrophied GFAP positive astrocytes were conspicuous around periphery of the lesion but absent within the core of the lesion at these times. At longer survival intervals (1-2 months), the number of FJ-C labeled degenerating neurons was greatly reduced, while GFAP staining essentially returned to base line and laminin expression remained noticeably elevated, although the vessels appeared to be intact morphologically. These data allow for speculation on possible mechanisms underlying these events.


Asunto(s)
Barrera Hematoencefálica/efectos de los fármacos , Ácido Kaínico/toxicidad , Laminina/biosíntesis , Degeneración Nerviosa/patología , Degeneración Nerviosa/fisiopatología , Animales , Astrocitos/metabolismo , Astrocitos/patología , Barrera Hematoencefálica/metabolismo , Barrera Hematoencefálica/fisiopatología , Arterias Cerebrales/efectos de los fármacos , Arterias Cerebrales/metabolismo , Arterias Cerebrales/fisiopatología , Modelos Animales de Enfermedad , Progresión de la Enfermedad , Proteína Ácida Fibrilar de la Glía/biosíntesis , Proteína Ácida Fibrilar de la Glía/metabolismo , Gliosis/metabolismo , Gliosis/patología , Gliosis/fisiopatología , Laminina/agonistas , Laminina/metabolismo , Masculino , Neurotoxinas/toxicidad , Ratas , Ratas Sprague-Dawley , Factores de Tiempo , Regulación hacia Arriba/efectos de los fármacos , Regulación hacia Arriba/fisiología
3.
J Biosci Bioeng ; 108(2): 174-7, 2009 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-19619867

RESUMEN

The dynamic behaviors of human skeletal muscle myoblasts were investigated in the culture on a laminin-coated surface in the presence of 100 ng/ml epidermal growth factor (EGF) in medium. The coexistence of laminin and EGF caused the enhancement of myoblast migration, giving an average migration rate of 62.0 microm/h, which was 2.7 times that on a plain surface. This encouraged migration could be a driving force to separate the dividing cells from each other, accompanied by shortened disjunction time of daughter cells to complete cytokinesis. In addition, the synergic effect of laminin and EGF led to the promotion of myoblast growth with keeping a relatively high fraction of proliferative cells during the culture for 150 h, which is considered to arise from the reduced frequency of cell-cell contacts during cytokinesis and thereby suppressing the process towards myotube formation after cell division.


Asunto(s)
Comunicación Celular/efectos de los fármacos , Movimiento Celular/efectos de los fármacos , Citocinesis/efectos de los fármacos , Factor de Crecimiento Epidérmico/farmacología , Laminina/farmacología , Mioblastos Esqueléticos/fisiología , Animales , Comunicación Celular/fisiología , Movimiento Celular/fisiología , Células Cultivadas , Relación Dosis-Respuesta a Droga , Sinergismo Farmacológico , Factor de Crecimiento Epidérmico/agonistas , Humanos , Laminina/agonistas , Ratones , Fibras Musculares Esqueléticas/citología , Fibras Musculares Esqueléticas/fisiología , Mioblastos Esqueléticos/citología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA